Provided by Tiger Fintech (Singapore) Pte. Ltd.

Silence Therapeutics Plc

3.14
+0.24008.28%
Post-market: 3.180.0400+1.27%18:05 EDT
Volume:296.46K
Turnover:916.48K
Market Cap:148.29M
PE:-3.21
High:3.22
Open:2.90
Low:2.88
Close:2.90
Loading ...

Silence Therapeutics Plc : Jefferies Cuts Target Price to $31 From $38

THOMSON REUTERS
·
21 Nov 2024

SLN Stock Down Despite Cholesterol Drug Lowering Lipoprotein Levels

Zacks
·
21 Nov 2024

Silence Therapeutics Price Target Maintained With a $75.00/Share by HC Wainwright & Co.

Dow Jones
·
20 Nov 2024

Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst

Benzinga
·
20 Nov 2024

Silence Therapeutics weakness after AHA updates ‘overdone,’ says BMO Capital

TIPRANKS
·
20 Nov 2024

SILENCE THERAPEUTICS PLC SPONSORED ADR trading resumes

TIPRANKS
·
20 Nov 2024

European Equities Traded in the US as American Depositary Decline Slightly in Tuesday Trading

MT Newswires Live
·
20 Nov 2024

Silence Therapeutics Showcases Promising Phase 2 Results

TIPRANKS
·
19 Nov 2024

Silence Therapeutics presents late-breaking Phase 2 zerlasiran data at AHA

TIPRANKS
·
19 Nov 2024

Silence Therapeutics Presents Late-Breaking Phase 2 Zerlasiran Data at 2024 American Heart Association (AHA) Annual Meeting

Business Wire
·
19 Nov 2024

Silence Therapeutics Third Quarter 2024 Earnings: Misses Expectations

Simply Wall St.
·
17 Nov 2024

Silence Therapeutics Q3 EPS $(0.21) Down From $(0.09) YoY, Sales $1.25M Down From $3.54M YoY

Benzinga
·
14 Nov 2024

Silence Therapeutics to Participate in Fireside Chat at the Jefferies London Healthcare Conference

Business Wire
·
13 Nov 2024

European Equities Traded in the US as American Depositary Fall Sharply in Tuesday Trading

MT Newswires Live
·
13 Nov 2024

European Equities Traded in the US as American Depositary Receipts Close Bearish Week on High Note Friday

MT Newswires Live
·
01 Nov 2024

Is Silence Therapeutics plc (SLN) a Promising Gene Editing Stock?

Insider Monkey
·
31 Oct 2024

Eramet: Adjusted turnover of €809m in Q3 2024

GlobeNewswire
·
24 Oct 2024

Silence Therapeutics files automatic ordinary shares offering

TIPRANKS
·
23 Oct 2024